The Source for Health Care Policy and Medical Writing, Editing, Payer Consulting, and Market Research
We know the language of the payer markets and managed care, from Access to Value-Based Contracting, and beyond…
Dedicated to helping you navigate the difficult waters of health care editorial content and consulting.
Editorial Services
SM Health Communications provides an array of expertise in medical/health care writing and editing. Our writers have covered the entire spectrum, from highly technical clinical issues, health policy research and reviews, payer markets, and news features geared to the lay public.
Market Research
Specializing in the payer markets, we provide in-depth telephone interviews, comprehensive Web-based surveys, and tools to help you get the answers you need for key decision makers as quickly and cost effectively as possible. Ask us about our unique market research products to meet your immediate market access challenges.
Mock P&T Committees
Before launch and even postlaunch, the biopharmaceutical, device, and diagnostics industries need business intelligence on whether their product’s value proposition and market positioning will result in advantaged, disadvantaged, or parity placement compared with that of their competitors. Our mock P&T Committee capabilities will cost effectively and reliably fill in the blanks — this is an outcomes test of your payer markets access strategy!
See our sister site Biosimilars Review & Reports for postings on the rapidly changing biosimilar arena.
Project Management and Custom Publishing
Have a meeting that you need covered and converted to a monograph? Have a meeting that you want to hold but don’t know how to get started in reaching your audience? SM Health Communications has the answers and expertise to turn that symposium or clinical track into a marketable monograph, distributed to a customizable group of audiences. SM Health Communications can connect your monograph to a recognized publication with the distribution to meet your needs!
Now Available from SM Health Communications
What our clients are saying…
I have had the pleasure of working with Stan Mehr on several client projects over the past several years. Stan is a consummate professional and Market Access subject matter expert. He has brought valuable insights and well-tuned perspectives to all of our engagements. He has clearly demonstrated the strong ability to flex based on client needs and changing priorities. As a trusted partner, Stan has built enduring relationships with our team and our clients. I sincerely hope to have the opportunity to work with Stan again.
Mike Motto
SVP, Market Access
Eversana Intouch
SM Health Communications has been a consistent go-to resource for me to gain market access insights. I am an account VP for a marketing agency and support several large pharmaceutical companies on new drug launches and strategies for continued growth of their existing product portfolios. In this everchanging market access space, it is imperative to understand the evolving PBM and payer space in order to provide strategic direction to my clients.
Stan has been an invaluable resource to me over the last several years. He keeps me and my teams informed of recent market developments including PBM/payer consolidation, new regulations, and he has a keen understanding of the specialty drug and biosimilar market landscape. He is also extremely reliable during tight timelines. If you are looking for market access, specialty drug or biosimilar expertise, I highly recommend SM Health Communications.
Elisa Boyle
Vice President
The Kinetix Group
Featured from our Discussions, helpful information on the payer markets!
The Employer Is a Fiduciary for Its Employees Under ERISA, not an ATM for Its PBM
A lawsuit filed by Johnson & Johnson employees against the drug manufacturer’s employee benefits operation on February 6 spotlights the potential, substantial liability for self-insured employers not adequately managing their pharmacy benefits. At issue is the...
Will PBMs Survive the Rush of Legislative Proposals to Restrict Their Practices?
Surely, these can be trying times for pharmacy benefit manager (PBM) C-suite executives. They have been through a revolving door of Congressional hearings, and their responses have resulted in a constant shower of legislative proposals to deprive them of the shield of...
See our sister site Biosimilars Review & Reports for postings on the rapidly changing biosimilar arena.
We Are Experts in the Payer Markets and Clinical Policy
If your organization needs highly experienced payer markets writing and content, contact SM Health Communications today.